Bruno Lina

InstitutionUniversité de Lyon
AddressLyon
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 46 Covid-19 publications, with a maximum of 5 publications in July 2020 and January 2021 and July 2021
    All Publications
    Bar chart showing 272 publications over 27 distinct years, with a maximum of 25 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Quéromès G, Destras G, Bal A, Regue H, Burfin G, Brun S, Fanget R, Morfin F, Valette M, Trouillet-Assant S, Lina B, Frobert E, Josset L. Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France. Emerg Microbes Infect. 2021 Dec; 10(1):167-177. PMID: 33399033.
      Citations: 15     Fields:    Translation:HumansCells
    2. Saade C, Gonzalez C, Bal A, Valette M, Saker K, Lina B, Josset L, Trabaud MA, Thiery G, Botelho-Nevers E, Paul S, Verhoeven P, Bourlet T, Pillet S, Morfin F, Trouillet-Assant S, Pozzetto B. Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2. Emerg Microbes Infect. 2021 Dec; 10(1):1499-1502. PMID: 34176436.
      Citations: 1     Fields:    Translation:Humans
    3. Allam C, Gaymard A, Descours G, Ginevra C, Josset L, Bouscambert M, Beraud L, Ibranosyan M, Golfier C, Friggeri A, Lina B, Campèse C, Ader F, Jarraud S. Co-infection with Legionella and SARS-CoV-2, France, March 2020. Emerg Infect Dis. 2021 Nov; 27(11):2864-2868. PMID: 34469708.
      Citations:    Fields:    Translation:HumansCells
    4. Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, Villard M, Lina B, Richard JC, Fassier JB, Cheynet V, Padey B, Duliere V, Julien T, Paul S, Bastard P, Belot A, Bal A, Casanova JL, Rosa-Calatrava M, Morfin F, Walzer T, Trouillet-Assant S. Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 Oct 04; 218(10). PMID: 34415984.
      Citations: 1     Fields:    
    5. Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, Villard M, Lina B, Richard JC, Fassier JB, Cheynet V, Padey B, Duliere V, Julien T, Paul S, Bastard P, Belot A, Bal A, Casanova JL, Rosa-Calatrava M, Morfin F, Walzer T, Trouillet-Assant S. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 10 04; 218(10). PMID: 34357402.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    6. Destras G, Assaad S, Bal A, Bouscambert-Duchamp M, Avrillon V, Simon B, Valette M, Blay JY, Lina B, Frobert E, Josset L. Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19. Lancet Microbe. 2021 Sep; 2(9):e424. PMID: 34341781.
      Citations:    
    7. Bal A, Brengel-Pesce K, Gaymard A, Quéromès G, Guibert N, Frobert E, Bouscambert M, Trabaud MA, Allantaz-Frager F, Oriol G, Cheynet V, d'Aubarede C, Massardier-Pilonchery A, Buisson M, Lupo J, Pozzetto B, Poignard P, Lina B, Fassier JB, Morfin F, Trouillet-Assant S. Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study. Sci Rep. 2021 07 22; 11(1):14977. PMID: 34294751.
      Citations: 1     Fields:    Translation:Humans
    8. Charmet T, Schaeffer L, Grant R, Galmiche S, Chény O, Von Platen C, Maurizot A, Rogoff A, Omar F, David C, Septfons A, Cauchemez S, Gaymard A, Lina B, Lefrancois LH, Enouf V, van der Werf S, Mailles A, Levy-Bruhl D, Carrat F, Fontanet A. Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France. Lancet Reg Health Eur. 2021 Sep; 8:100171. PMID: 34278372.
      Citations: 5     
    9. van Summeren J, Meijer A, Aspelund G, Casalegno JS, Erna G, Hoang U, Lina B, de Lusignan S, Teirlinck AC, Thors V, Paget J. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? Euro Surveill. 2021 07; 26(29). PMID: 34296672.
      Citations: 4     Fields:    Translation:HumansCells
    10. Casalegno JS, Ploin D, Cantais A, Masson E, Bard E, Valette M, Fanget R, Targe SC, Myar-Dury AF, Doret-Dion M, Massoud M, Queromes G, Vanhems P, Claris O, Butin M, Pillet S, Ader F, Bin S, Gaymard A, Lina B, Morfin F, Javouhey E, Gillet Y. Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France. Euro Surveill. 2021 07; 26(29). PMID: 34296674.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    11. Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837. PMID: 34048876.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    12. Fourati S, Decousser JW, Khouider S, N'Debi M, Demontant V, Trawinski E, Gourgeon A, Gangloff C, Destras G, Bal A, Josset L, Soulier A, Costa Y, Gricourt G, Lina B, Lepeule R, Pawlotsky JM, Rodriguez C. Novel SARS-CoV-2 Variant Derived from Clade 19B, France. Emerg Infect Dis. 2021 05; 27(5):1540-1543. PMID: 33900195.
      Citations: 7     Fields:    Translation:Humans
    13. Terrier O, Dilly S, Pizzorno A, Chalupska D, Humpolickova J, Boura E, Berenbaum F, Quideau S, Lina B, Fève B, Adnet F, Sabbah M, Rosa-Calatrava M, Maréchal V, Henri J, Slama-Schwok A. Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus. Molecules. 2021 Apr 29; 26(9). PMID: 33946802.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    14. Bal A, Pozzetto B, Trabaud MA, Escuret V, Rabilloud M, Langlois-Jacques C, Paul A, Guibert N, D'Aubarède-Frieh C, Massardier-Pilonchery A, Fabien N, Goncalves D, Boibieux A, Morfin-Sherpa F, Pitiot V, Gueyffier F, Lina B, Fassier JB, Trouillet-Assant S. Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test. Clin Chem. 2021 04 29; 67(5):742-752. PMID: 33399823.
      Citations: 17     Fields:    Translation:Humans
    15. Citations: 6     Fields:    Translation:Animals
    16. Gaymard A, Bosetti P, Feri A, Destras G, Enouf V, Andronico A, Burrel S, Behillil S, Sauvage C, Bal A, Morfin F, Van Der Werf S, Josset L, Blanquart F, Coignard B, Cauchemez S, Lina B. Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021. Euro Surveill. 2021 03; 26(9). PMID: 33663644.
      Citations: 19     Fields:    Translation:Humans
    17. Atlani-Duault L, Lina B, Chauvin F, Delfraissy JF, Malvy D. Immune evasion means we need a new COVID-19 social contract. Lancet Public Health. 2021 04; 6(4):e199-e200. PMID: 33610196.
      Citations: 2     Fields:    Translation:Humans
    18. Fontanet A, Autran B, Lina B, Kieny MP, Karim SSA, Sridhar D. SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet. 2021 03 13; 397(10278):952-954. PMID: 33581803.
      Citations: 102     Fields:    Translation:HumansPHPublic Health
    19. Picaud JC, Buffin R, Rigourd V, Boscher C, Lamireau D, Dumoulin D, Voirin F, Lefur S, Frange P, Lina B. It's time to change the recommendations on COVID-19 and human milk donations. Acta Paediatr. 2021 05; 110(5):1405-1406. PMID: 33527456.
      Citations: 2     Fields:    Translation:Humans
    20. Tubiana S, Burdet C, Houhou N, Thy M, Manchon P, Blanquart F, Charpentier C, Guedj J, Alavoine L, Behillil S, Leclercq A, Lucet JC, Yazdanpanah Y, Attia M, Demeret C, Rose T, Bielicki JA, Bruijning-Verhagen P, Goossens H, Descamps D, van der Werf S, Lina B, Duval X. High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort. J Infect. 2021 05; 82(5):186-230. PMID: 33545165.
      Citations: 2     Fields:    Translation:Humans
    21. Souty C, Guerrisi C, Masse S, Lina B, van der Werf S, Bernard-Stoecklin S, Turbelin C, Falchi A, Hanslik T, Blanchon T. Impact of the lockdown on the burden of COVID-19 in outpatient care in France, spring 2020. Infect Dis (Lond). 2021 05; 53(5):376-381. PMID: 33512254.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    22. Vanhems P, Gustin MP, Elias C, Henaff L, Dananché C, Grisi B, Marion E, Khanafer N, Hilliquin D, Gardes S, Gerbier-Colomban S, Amour S, Kuczewski E, Escuret V, Lina B, Saadatian-Elahi M. Factors associated with admission to intensive care units in COVID-19 patients in Lyon-France. PLoS One. 2021; 16(1):e0243709. PMID: 33503018.
      Citations: 4     Fields:    Translation:Humans
    23. Bal A, Trabaud MA, Fassier JB, Rabilloud M, Saker K, Langlois-Jacques C, Guibert N, Paul A, Alfaiate D, Massardier-Pilonchery A, Pitiot V, Morfin-Sherpa F, Lina B, Pozzetto B, Trouillet-Assant S. Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays. Clin Microbiol Infect. 2021 Jun; 27(6):933-935. PMID: 33450388.
      Citations: 4     Fields:    Translation:Humans
    24. Bal A, Destras G, Gaymard A, Stefic K, Marlet J, Eymieux S, Regue H, Semanas Q, d'Aubarede C, Billaud G, Laurent F, Gonzalez C, Mekki Y, Valette M, Bouscambert M, Gaudy-Graffin C, Lina B, Morfin F, Josset L. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020. Euro Surveill. 2021 01; 26(3). PMID: 33478625.
      Citations: 57     Fields:    Translation:HumansCells
    25. Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S. Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France. Euro Surveill. 2021 01; 26(1). PMID: 33413741.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    26. Nicolas de Lamballerie C, Pizzorno A, Fouret J, Szpiro L, Padey B, Dubois J, Julien T, Traversier A, Dulière V, Brun P, Lina B, Rosa-Calatrava M, Terrier O. Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model. Microorganisms. 2020 Dec 11; 8(12). PMID: 33322535.
      Citations: 1     
    27. Bitker L, Dhelft F, Chauvelot L, Frobert E, Folliet L, Mezidi M, Trouillet-Assant S, Belot A, Lina B, Wallet F, Richard JC. Protracted viral shedding and viral load are associated with ICU mortality in Covid-19 patients with acute respiratory failure. Ann Intensive Care. 2020 Dec 10; 10(1):167. PMID: 33301059.
      Citations: 9     
    28. Baay M, Lina B, Fontanet A, Marchant A, Saville M, Sabot P, Vandeputte J, Neels P. Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic. Biologicals. 2021 Jan; 69:76-82. PMID: 33234420.
      Citations:    Fields:    Translation:HumansPHPublic Health
    29. Atlani-Duault L, Lina B, Malvy D, Yazdanpanah Y, Chauvin F, Delfraissy JF. COVID-19: France grapples with the pragmatics of isolation. Lancet Public Health. 2020 11; 5(11):e573-e574. PMID: 33045184.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    30. Charre C, Ginevra C, Sabatier M, Regue H, Destras G, Brun S, Burfin G, Scholtes C, Morfin F, Valette M, Lina B, Bal A, Josset L. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation. Virus Evol. 2020 Jul; 6(2):veaa075. PMID: 33318859.
      Citations: 26     
    31. Charre C, Icard V, Pradat P, Brochier C, Lina B, Chidiac C, Cotte L. Coronavirus disease 2019 attack rate in HIV-infected patients and in preexposure prophylaxis users. AIDS. 2020 10 01; 34(12):1765-1770. PMID: 32889852.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    32. Trabaud MA, Icard V, Milon MP, Bal A, Lina B, Escuret V. Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody. J Clin Virol. 2020 11; 132:104613. PMID: 32942137.
      Citations: 20     Fields:    Translation:Humans
    33. Paget J, Caini S, Cowling B, Esposito S, Falsey AR, Gentile A, Kyncl J, MacIntyre C, Pitman R, Lina B. The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies. Vaccine. 2020 09 29; 38(42):6485-6486. PMID: 32859436.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    34. Danis K, Epaulard O, Bénet T, Gaymard A, Campoy S, Botelho-Nevers E, Bouscambert-Duchamp M, Spaccaferri G, Ader F, Mailles A, Boudalaa Z, Tolsma V, Berra J, Vaux S, Forestier E, Landelle C, Fougere E, Thabuis A, Berthelot P, Veil R, Levy-Bruhl D, Chidiac C, Lina B, Coignard B, Saura C. Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020. Clin Infect Dis. 2020 07 28; 71(15):825-832. PMID: 32277759.
      Citations: 98     Fields:    Translation:HumansCellsPHPublic Health
    35. Maisonnasse P, Guedj J, Contreras V, Behillil S, Solas C, Marlin R, Naninck T, Pizzorno A, Lemaitre J, Gonçalves A, Kahlaoui N, Terrier O, Fang RHT, Enouf V, Dereuddre-Bosquet N, Brisebarre A, Touret F, Chapon C, Hoen B, Lina B, Calatrava MR, van der Werf S, de Lamballerie X, Le Grand R. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020 09; 585(7826):584-587. PMID: 32698191.
      Citations: 123     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    36. Pizzorno A, Padey B, Julien T, Trouillet-Assant S, Traversier A, Errazuriz-Cerda E, Fouret J, Dubois J, Gaymard A, Lescure FX, Dulière V, Brun P, Constant S, Poissy J, Lina B, Yazdanpanah Y, Terrier O, Rosa-Calatrava M. Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia. Cell Rep Med. 2020 07 21; 1(4):100059. PMID: 32835306.
      Citations: 62     
    37. Atlani-Duault L, Chauvin F, Yazdanpanah Y, Lina B, Benamouzig D, Bouadma L, Druais PL, Hoang A, Grard MA, Malvy D, Delfraissy JF. France's COVID-19 response: balancing conflicting public health traditions. Lancet. 2020 07 25; 396(10246):219-221. PMID: 32682489.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    38. Pizzorno A, Padey B, Dubois J, Julien T, Traversier A, Dulière V, Brun P, Lina B, Rosa-Calatrava M, Terrier O. In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. Antiviral Res. 2020 09; 181:104878. PMID: 32679055.
      Citations: 32     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    39. Baay M, Lina B, Fontanet A, Marchant A, Saville M, Sabot P, Duclos P, Vandeputte J, Neels P. SARS-CoV-2: Virology, epidemiology, immunology and vaccine development. Biologicals. 2020 Jul; 66:35-40. PMID: 32600951.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    40. Destras G, Bal A, Escuret V, Morfin F, Lina B, Josset L. Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic. Lancet Microbe. 2020 Aug; 1(4):e149. PMID: 32835345.
      Citations: 31     
    41. Trouillet-Assant S, Viel S, Gaymard A, Pons S, Richard JC, Perret M, Villard M, Brengel-Pesce K, Lina B, Mezidi M, Bitker L, Belot A. Type I IFN immunoprofiling in COVID-19 patients. J Allergy Clin Immunol. 2020 Jul; 146(1):206-208.e2. PMID: 32360285.
      Citations: 103     Fields:    Translation:HumansCellsPHPublic Health
    42. Boëlle PY, Souty C, Launay T, Guerrisi C, Turbelin C, Behillil S, Enouf V, Poletto C, Lina B, van der Werf S, Lévy-Bruhl D, Colizza V, Hanslik T, Blanchon T. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020. Euro Surveill. 2020 04; 25(14). PMID: 32290901.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    43. Bal A, Destras G, Gaymard A, Bouscambert-Duchamp M, Valette M, Escuret V, Frobert E, Billaud G, Trouillet-Assant S, Cheynet V, Brengel-Pesce K, Morfin F, Lina B, Josset L. Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del). Clin Microbiol Infect. 2020 07; 26(7):960-962. PMID: 32234449.
      Citations: 27     Fields:    Translation:HumansCellsPHPublic Health
    44. Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 06; 20(6):697-706. PMID: 32224310.
      Citations: 401     Fields:    Translation:HumansCellsPHPublic Health
    45. Citations: 181     Fields:    Translation:HumansCellsPHPublic Health
    Lina's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (348)
    Explore
    _
    Co-Authors (436)
    Explore
    _
    Similar People (60)
    Explore
    _